CellsBin is a VC-backed startup that offers drug discovery, immunotherapy, and toxicity testing.
CellsBin has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in October 2026.
CellsBin's investors include Plug and Play, 108 BioCapital, National Cancer Institute.
CellsBin is headquartered in New Haven, United States.
CellsBin is a VC-backed startup that offers drug discovery, immunotherapy, and toxicity testing.
CellsBin is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CellsBin — Funding & Investors." VCBacked, October 27, 2026, https://www.vcbacked.co/company/cellsbin. Accessed November 1, 2026.
VCBacked. (2026). CellsBin — Funding & Investors. Retrieved November 1, 2026, from https://www.vcbacked.co/company/cellsbin
{{cite web |title=CellsBin — Funding & Investors |url=https://www.vcbacked.co/company/cellsbin |website=VCBacked |access-date=November 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated